127 related articles for article (PubMed ID: 2423490)
1. Unstability of neocarzinostatin-chromophore.
Edo K; Sato H; Saito K; Akiyama Y; Kato M; Mizugaki M; Koide Y; Ishida N
J Antibiot (Tokyo); 1986 Apr; 39(4):535-40. PubMed ID: 2423490
[TBL] [Abstract][Full Text] [Related]
2. An antitumor polypeptide antibiotic neocarzinostatin: the mode of apo-protein--chromophore interaction.
Edo K; Saito K; Akiyama-Murai Y; Mizugaki M; Koide Y; Ishida N
J Antibiot (Tokyo); 1988 Apr; 41(4):554-62. PubMed ID: 2967272
[TBL] [Abstract][Full Text] [Related]
3. Neocarzinostatin chromophore. Assignment of spectral properties and structural requirements for binding to DNA.
Napier MA; Goldberg IH
Mol Pharmacol; 1983 Mar; 23(2):500-10. PubMed ID: 6220205
[TBL] [Abstract][Full Text] [Related]
4. Neocarzinostatin: selective tryptophan oxidation and neocarzinostatin-chromophore binding to apo-neocarzinostatin.
Edo K; Saito K; Matsuda Y; Akiyama-Murai Y; Mizugaki M; Koide Y; Ishida N
Chem Pharm Bull (Tokyo); 1991 Jan; 39(1):170-6. PubMed ID: 1828722
[TBL] [Abstract][Full Text] [Related]
5. Enzyme-linked immunosorbent assay of neocarzinostatin chromophore (NCS-chr) by use of a monoclonal antibody against NCS-chr analog.
Mizugaki M; Itoh K; Nakamura H; Ishida N
J Immunoassay; 1996 May; 17(2):133-44. PubMed ID: 8744283
[TBL] [Abstract][Full Text] [Related]
6. Roles of chromophore and apo-protein in neocarzinostatin action.
Kappen LS; Napier MA; Goldberg IH
Proc Natl Acad Sci U S A; 1980 Apr; 77(4):1970-4. PubMed ID: 6445563
[TBL] [Abstract][Full Text] [Related]
7. Gamma-radiolysis study of the reductive activation of neocarzinostatin by the carboxyl radical.
Favaudon V
Biochimie; 1983; 65(11-12):593-607. PubMed ID: 6231960
[TBL] [Abstract][Full Text] [Related]
8. Characterization of secondary structure of neocarzinostatin apoprotein.
Saito K; Sato Y; Edo K; Akiyama-Murai Y; Koide Y; Ishida N; Mizugaki M
Chem Pharm Bull (Tokyo); 1989 Nov; 37(11):3078-82. PubMed ID: 2534360
[TBL] [Abstract][Full Text] [Related]
9. [Biochemical mechanisms of NCS-chromophore-induced DNA cleavage and inhibition of protein kinase activity].
Ohtsuki K; Tanoue S; Karino A
Gan To Kagaku Ryoho; 1997 Feb; 24(4):443-53. PubMed ID: 9063482
[TBL] [Abstract][Full Text] [Related]
10. Design, production, and characterization of recombinant neocarzinostatin apoprotein in Escherichia coli.
Nozaki S; Tomioka Y; Hishinuma T; Inoue M; Nagumo Y; Tsuruta LR; Hayashi K; Matsumoto T; Kato Y; Ishiwata S; Itoh K; Suzuki T; Hirama M; Mizugaki M
J Biochem; 2002 May; 131(5):729-38. PubMed ID: 11983081
[TBL] [Abstract][Full Text] [Related]
11. Neocarzinostatin chromophore: presence of a highly strained ether ring and its reaction with mercaptan and sodium borohydride.
Hensens OD; Dewey RS; Liesch JM; Napier MA; Reamer RA; Smith JL; Albers-Schönberg G; Goldberg IH
Biochem Biophys Res Commun; 1983 Jun; 113(2):538-47. PubMed ID: 6223633
[TBL] [Abstract][Full Text] [Related]
12. Induced formation of a DNA bulge structure by a molecular wedge ligand-postactivated neocarzinostatin chromophore.
Gao X; Stassinopoulos A; Ji J; Kwon Y; Bare S; Goldberg IH
Biochemistry; 2002 Apr; 41(16):5131-43. PubMed ID: 11955061
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of activation of the antitumor antibiotic neocarzinostatin by mercaptan and sodium borohydride.
Hensens OD; Goldberg IH
J Antibiot (Tokyo); 1989 May; 42(5):761-8. PubMed ID: 2524463
[TBL] [Abstract][Full Text] [Related]
14. Gene transcription analysis of Saccharomyces cerevisiae exposed to neocarzinostatin protein-chromophore complex reveals evidence of DNA damage, a potential mechanism of resistance, and consequences of prolonged exposure.
Schaus SE; Cavalieri D; Myers AG
Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11075-80. PubMed ID: 11562456
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanism of novel DNA sugar damage by an antitumour protein antibiotic.
Goldberg IH; Kappen LS; Povirk LF; Chin DH
Drugs Exp Clin Res; 1986; 12(6-7):495-505. PubMed ID: 2943568
[TBL] [Abstract][Full Text] [Related]
16. Sequence-specific, strand-selective, and directional binding of neocarzinostatin chromophore to oligodeoxyribonucleotides.
Lee SH; Goldberg IH
Biochemistry; 1989 Feb; 28(3):1019-26. PubMed ID: 2523731
[TBL] [Abstract][Full Text] [Related]
17. Stabilization of neocarzinostatin nonprotein chromophore activity by interaction with apoprotein and with HeLa cells.
Kappen LS; Goldberg IH
Biochemistry; 1980 Oct; 19(21):4786-90. PubMed ID: 6448635
[TBL] [Abstract][Full Text] [Related]
18. Selective strand scission by intercalating drugs at DNA bulges.
Williams LD; Goldberg IH
Biochemistry; 1988 Apr; 27(8):3004-11. PubMed ID: 2456781
[TBL] [Abstract][Full Text] [Related]
19. Neocarzinostatin chromophore: purification of the major active form and characterization of its spectral and biological properties.
Napier MA; Holmquist B; Strydom DJ; Goldberg IH
Biochemistry; 1981 Sep; 20(19):5602-8. PubMed ID: 6457635
[No Abstract] [Full Text] [Related]
20. Binding and cleavage characteristics of the complexes formed between the neocarzinostatin chromophore and single site containing oligonucleotides.
Stassinopoulos A; Goldberg IH
Bioorg Med Chem; 1995 Jun; 3(6):713-21. PubMed ID: 7582949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
